FdaApplication

ANDA 215234

Back to search

Identifiers

Properties

PropertyValue
applicant_nameZYDUS PHARMACEUTICALS USA INC
application_typeANDA
approval_date2021-07-29

Products (1)

ProductActive ingredientStrengthDosage form
FULVESTRANTFULVESTRANT250MG/5ML (50MG/ML)SOLUTION;INTRAMUSCULAR

1 product